Vasoactive intestinal peptide releases interleukin-1 from astrocytes

Annals of the New York Academy of Sciences

Volumn 805, Issue , 1996, Pages 280-287

  Brenneman, Douglas E ^a   Hill, Joanna M ^a   Gozes, Illana ^b   Phillips, Terry M ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ASTROCYTE; BRAIN; CELL CULTURE; CONFERENCE PAPER; NEUROTRANSMISSION; NONHUMAN; RAT;

EID: 0030481080     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb17490.x     Document Type: Conference Paper

References (31)

1. BRENNEMAN, D. E. & L. E. EIDEN. 1986. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. USA 83: 1159-1162.
2. BRENNEMAN, D. E., L. E. EIDEN & R. E. SIEGEL. 1985. Neurotrophic action of VIP on spinal cord cultures. Peptides 6 (Suppl. 2): 35-39.
3. BRENNEMAN, D. E., G. L. WESTBROOK, S. P. FITZGERALD, D. L. ENNIST, K. L. ELKINS, M. R. RUFF & C. B. PERT. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639-642.
4. ARIMURA, A., A. SOMOGYVARI-VIGH, C. WEILL, R. C. FIORE, I. TATSUNO, V. BAY & D. E. BRENNEMAN. 1994. PACAP functions as a neurotrophic factor. Ann. N.Y. Acad. Sci. 739: 228-243.
5. GRESSENS, P., J. M. HILL, I. GOZES, M. FRIDKIN & D. E. BRENNEMAN. 1993. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 362: 155-158.
6. PINCUS, D. W., E. DICICCO-BLOOM & I. B. BLACK. 1990. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 343: 565-567.
7. BRENNEMAN, D. E., E. A. NEALE, G. A. FOSTER, S. d'AUTREMONT & G. WESTBROOK. 1987. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J. Cell Biol. 104: 1603-1610.
8. BRENNEMAN, D. E., T. NICOL, D. WARREN & L. M. BOWERS. 1990. Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25: 386-394.
9. FATATIS, A., L. A. HOLTZCLAW, R. AVIDOR, D. E. BRENNEMAN & J. T. RUSSELL. 1994. Vasoactive intestinal peptide increases intracellular calcium in astroglia: Synergism with alpha-adrenergic receptors. Proc. Natl. Acad. Sci. USA 91: 2036-2040.
10. OLAH, Z., C. LEHEL, W. B. ANDERSON, D. E. BRENNEMAN & D. V. AGOSTON. 1994. Subnanomolar concentrations of VIP induce the nuclear translocation of protein kinase C in neonatal rat cortical astrocytes. J. Neurosci. Res. 39: 355-363.
11. BRENNEMAN, D. E., M. SCHULTZBERG, T. BARTFAI & I. GOZES. 1992. Cytokine regulation of neuronal survival. J. Neurochem. 58: 454-460.
12. ALOISI, F., S. ROSA, U. TESTA, P. BONSI, G. RUSSO, C. PESCHALE & G. LEVI. 1994. Regulation of leukemia inhibitory factor synthesis in cultured human astrocytes. J. Immunol. 152: 5022-5031.
13. KUUSHIMA, Y., T. HAMA & H. HATANAKA. 1992. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neurosci. Res. 13: 267-280.
14. GOTTSCHALL, P. E., I. TATSUNO & A. ARIMURA. 1994. Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: Synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res. 637: 197-203.
15. MERRILL, J. E. & G. M. JONAKAIT. 1995. Interactions of the nervous system and immune systems in development, normal brain homeostasis and disease. FASEB J. 9: 611 -618.
16. DINARELLO, C. A. 1984. Interleukin-1. Rev. Infect. Dis. 6: 51-95.
17. LOMEDICO, P. T., P. L. KILLAN, U. GUBLER, A. S. STERN & R. CHIZZONITE. 1986. Molecular biology of interleukin-1. Cold Spring Harbor Symp. Quant. Biol. 51: 631-635.
18. LOMEDICO, P. T., U. GUBLER, C. P. HELLMAN, M. DUKOVICH, J. G. GIRI, Y. E. PAN, K. COLLIER, R. SEMINOW, A. O. CHUA & S. B. MIZEL. 1984. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 315: 641-647.
19. DACUNHA, A., J. J. JEFFERSON, W. R. TYOR, J. D. GLASS, F. S. JANNOTTA & L. VITKOVIC. 1993. Control of astrocytosis by interleukin-1 and transforming growth factor-beta 1 in human brain. Brain Res. 631: 39-45.
20. GIULIAN, D., T. J. BAKER, L. N. SHIH & L. B. LACHMAN. 1986. Interleukin-1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164: 594-604.
21. LEE, S. C., W. LIU, D. W. DICKSON, C. F. BROSNAN & J. W. BERMAN. 1993. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150: 2659-2667.
22. ROTHWELL, N. J. & J. K. RELTON. 1993. Involvement of interleukin-1 and lipocortin-1 in ischemic brain damage. Cerebrovasc. Brain Metab. Rev. 5: 178-198.
23. GIULIAN, D., J. WOODWARD, D. G. YOUNG, J. F. KREBS & L. B. LACHMAN. 1988. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8: 2485-2490.
24. ROTHWELL, N. J. & G. LUHESHI. 1994. Pharmacology of interleukin-1 actions in the brain. Adv. Pharmacol. 25: 1-20.
25. MCCARTHY, K. D. & J. DE VELLIS. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85: 890-898.
26. WATKINS, B. A., H. H. DORN, W. B. KELLY, C. ARMSTRONG, B. POTTS, F. MICHAELS, C. V. KUFTA & M. DUBOIS-DALCQ. 1990. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 249: 549-553.
27. PHILLIPS, T. M. & P. L. KIMMEL. 1994. High-performance capillary electrophoretic analysis of inflammatory cytokines in human biopsies. J. Chromatogr. 656: 259-266.
28. PHILLIPS, T. M. 1993. Measurement of tissue cytokines by high-performance capillary electrophoresis. LC-GC. 11: 36-42.
29. BRENNEMAN, D. E., S. W. PAGE, M. SCHULZBERG, F. S. THOMAS, P. ZELAZOWSKI, P. BURNET, R. AVIDOR & E. M. STERNBERG. 1993. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partially interleukin-1-dependent mechanisms. J. Pharmacol. Exp. Ther. 266: 1029-1035.
30. BRENNEMAN, D. E., J. M. HILL, I. GOZES & T. M. PHILLIPS. 1994. Vasoactive intestinal peptide increases the secretion of eight cytokines from cerebral cortical astrocytes. Soc. Neurosci. Abstr. 20: 695.
31. BRENNEMAN, D. E., J. M. HILL, G. W. GLAZNER, I. GOZES & T. W. PHILIPS. 1995. Interleukin-1 alpha and vasoactive intestinal peptide: Enigmatic regulation of neuronal survival. Int. J. Dev. Neurosci. 13: 187-200.